GPR158 and prostate carcinoma: This could be related to the specific pathobiology of prostate cancer, where enrichment of GPR158 expressing neuroendocrine cells (thought to represent transdifferentiated prostate epithelial cells) show more aggressive clinical behaviour and thus are associated with poorer survival.